Restless leg syndrome. Restless legs syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 18 to 60 years Having symptoms for at least 15 days during the 30 days leading up to the start of the intervention Satisfaction with the completion of the project Having 4 criterias Patients with at least moderate symptoms Stop taking any medication for the treatment of restless leg syndrome at least two weeks before
Exclusion criteria
Exclusion criteria: Pregnancy or breastfeeding Reluctance to treat local vibration The presence of a pacemaker or ICD Existence of active malignancy Existence of fracture, open wound, abscess, cellulitis or infection at the place of vibration CKD (GFR<60) Iron deficiency anemia (ferritin less than 20) Vitamin deficiency (Vit D level < 30) Deep vein thrombosis (DVT) Evidence of radicular pain, radiculopathy or neuropathy (clinical or paraclinical evidence) Background diseases such as diabetes, thyroid diseases, Parkinson's, rheumatological diseases and... The history of the company in research projects for the treatment of restless legs syndrome at least during the last month. History of drug or alcohol abuse Psychological disorders (such as depression, anxiety disorder, etc.) or any cognitive disorder Movement disorders (tremor, dystonia, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of symptoms and restlessness of the legs. Timepoint: Before the beginning, after the last session and one month after the end of the intervention. Method of measurement: International Restless Leg Syndrome Study Group Rating Scale (IRLSRS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep quality. Timepoint: Before the beginning, after the last session and one month after the end of the intervention. Method of measurement: Standardized questionnaire Pittsburg in Farsi. | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences